KRAS and familial pancreatic carcinoma: Interestingly, the transcriptional and metabolic changes induced by the stromal secretome overlapped with those induced by oncogenic KRAS, indicating that the stromal reaction might cooperate with oncogenic alterations in KRAS to drive pancreatic cancer progression [50].